| Competing risks analysis highlights new targets in preventing ESRD and death ... - Science Centric |
|
|
Science Centric Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease (ESRD) and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome |